Weekly growth hormone treatment for children approved by European Medicines Agency

The European Medicines Agency has approved the once-weekly administration of lonapegsomatropin (TransCon hGH, Ascendis Pharma) for 3-18 year olds to treat growth hormone deficiency.

Medscape